NCT04051684

Regional TAP Block for Bariatric Patients

Transverse Abdominal Plane Blocks for Bariatric Surgery Patients: A Single Blinded Randomized Controlled Study

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 23 (actual)
• Sponsor: Montefiore Medical Center · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

Addition of transverse abdominis plane (TAP) block to general anesthesia for morbidly obese patients (BMI \>35) undergoing laparoscopic bariatric surgery for weight loss will significantly reduce opioid use in the recovery room

Conditions

• Bariatric Surgery
• Transverse Abdominal Plane Regional Blocks

Interventions

Type	Name	Description
PROCEDURE	Transverse abdominal plane block	Regional anesthesia team will perform a single shot TAP block with 0.5% ropivacaine 15-20 ml / side under ultrasound guided technique with blunt tipped, 21 gauge needle.
DRUG	Ropivacaine	Regional anesthesia team will perform a single shot TAP block with 0.5% ropivacaine 15-20 ml / side under ultrasound guided technique with blunt tipped, 21 gauge needle.

Timeline

• Start date: 2013-04-01
• Primary completion: 2013-05-01
• Completion: 2013-05-01
• First posted: 2019-08-09
• Last updated: 2019-12-03
• Results posted: 2019-12-03

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study